Duncan J J, Gordon N F, Scott C B
Division of Exercise Physiology, Cooper Institute for Aerobics Research, Dallas, TX 75230.
JAMA. 1991 Dec 18;266(23):3295-9.
We studied whether the quantity and quality of walking necessary to decrease the risk of cardiovascular disease among women differed substantially from that required to improve cardiorespiratory fitness.
A randomized, controlled, dose-response clinical trial with a follow-up of 24 weeks.
A private, nonprofit biomedical research facility.
One hundred two sedentary premenopausal women, 20 to 40 years of age, were randomized to one of four treatment groups; 59 completed the study (16 aerobic walkers [8.0-km/h group], 12 brisk walkers [6.4-km/h group], 18 strollers [4.8-km/h group], and 13 sedentary controls). Eighty-one percent were white, 17% black, and 2% Hispanic.
Intervention groups walked 4.8 km per day, 5 days per week at 8.0 km/h, 6.4 km/h, or 4.8 km/h on a tartan-surfaced, 1.6-km track for 24 weeks.
Fitness (determined by maximal oxygen uptake) and cardiovascular risk factors (determined by resting blood pressure and serum lipid and lipoprotein levels).
As compared with controls, maximal oxygen uptake increased significantly (P less than .0001) and in a dose-response manner (aerobic walkers greater than brisk walkers greater than strollers). In contrast, high-density lipoprotein cholesterol concentrations were not dose related and increased significantly (P less than .05) and to the same extent among women who experienced considerable improvements in their physical fitness (8.0-km/h group, +0.08 mmol/L) and those who had only minimal improvements in fitness (4.8-km/h group, +0.08 mmol/L). High-density lipoprotein cholesterol also increased among the 6.4-km/h group, but did not attain statistical significance (+0.06 mmol/L; P = .06). Dietary patterns revealed no significant differences among groups.
Thus, we conclude that vigorous exercise is not necessary for women to obtain meaningful improvements in their lipoprotein profile. Walking at intensities that do not have a major impact on cardiorespiratory fitness may nonetheless produce equally favorable changes in the cardiovascular risk profile.
我们研究了降低女性心血管疾病风险所需的步行量和质量是否与改善心肺适能所需的步行量和质量有显著差异。
一项随机、对照、剂量反应临床试验,随访24周。
一家私立非营利生物医学研究机构。
102名年龄在20至40岁之间久坐不动的绝经前女性被随机分为四个治疗组之一;59人完成了研究(16名有氧运动步行者[8.0公里/小时组]、12名轻快步行者[6.4公里/小时组]、18名漫步步行者[4.8公里/小时组]和13名久坐对照组)。81%为白人,17%为黑人,2%为西班牙裔。
干预组在一条1.6公里长的柏油跑道上,以8.0公里/小时、6.4公里/小时或4.8公里/小时的速度,每周5天,每天步行4.8公里,持续24周。
适能(通过最大摄氧量测定)和心血管危险因素(通过静息血压以及血脂和脂蛋白水平测定)。
与对照组相比,最大摄氧量显著增加(P<0.0001),且呈剂量反应关系(有氧运动步行者>轻快步行者>漫步步行者)。相比之下,高密度脂蛋白胆固醇浓度与剂量无关,在体能有显著改善的女性(8.0公里/小时组,+0.08毫摩尔/升)和体能仅有微小改善的女性(4.8公里/小时组,+0.08毫摩尔/升)中均显著增加(P<0.05),且增加程度相同。6.4公里/小时组的高密度脂蛋白胆固醇也有所增加,但未达到统计学显著性(+0.06毫摩尔/升;P=0.06)。各小组的饮食模式没有显著差异。
因此,我们得出结论,女性要想在脂蛋白水平上获得有意义的改善,并不一定需要剧烈运动。以对心肺适能没有重大影响的强度步行,仍可能在心血管风险状况方面产生同样有利的变化。